United States · FDA National Drug Code directory
Eletriptan hydrobromide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68382-923_669aad4d-c160-4be8-bca9-bdbaf0f3c8a3
- Product NDC
- 68382-923
- Form
- TABLET, FILM COATED
- Composition / generic term
- Eletriptan hydrobromide
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170712
- Source listing expiry
- 20261231
Source-listed ingredients
- ELETRIPTAN HYDROBROMIDE — 40 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 TABLET, FILM COATED in 1 BOTTLE (68382-923-05) · 68382-923-05
- 30 TABLET, FILM COATED in 1 BOTTLE (68382-923-06) · 68382-923-06
- 10 BLISTER PACK in 1 CARTON (68382-923-77) / 10 TABLET, FILM COATED in 1 BLISTER PACK (68382-923-30) · 68382-923-77
- 1 BLISTER PACK in 1 CARTON (68382-923-86) / 6 TABLET, FILM COATED in 1 BLISTER PACK · 68382-923-86
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →